Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerability
Germonpré, Paul, Van den Wyngaert, Tim, Roviello, GiandomenicoVolume:
14
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0215135
Date:
April, 2019
File:
PDF, 1.33 MB
english, 2019